Research Article
Efficacy and Safety of Daikenchuto for Constipation and Dose-Dependent Differences in Clinical Effects
Table 3
Clinical laboratory data of patients.
| | Prior to DKT administration | Three days after DKT administration | One week after DKT administration | value |
| Na (mEq/L) | 139 (136–141) | 137 (134–140) | 139 (137–140) | 0.318 | K (mEq/L) | 4.2 (4.0–4.5) | 4.2 (3.8–4.6) | 4.4 (3.9–4.7) | 0.0657 | Cl (mEq/L) | 102 (100–105) | 101 (99–105) | 102 (99–105) | 0.123 | AST (IU/L) | 20 (18–24) | 18 (13–28) | 21 (16–27) | 0.927 | ALT (IU/L) | 16 (12–23) | 13 (11–23) | 18 (11–25) | 0.513 | T-Bil (mg/dL) | 0.6 (0.4–0.7) | 0.5 (0.3–0.7) | 0.5 (0.4–0.7) | 0.284 | BUN (mg/dL) | 16 (14–21) | 19 (15–26) | 15 (10–24) | 0.368 | Cre (mg/dL) | 0.82 (0.62–1.0) | 0.7 (0.6–1.0) | 0.7 (0.6–0.9) | 0.744 | Alb (g/dL) | 3.4 (3.3–3.7) | 3.2 (2.7–3.8) | 3.2 (2.9–3.5) | 0.135 | BS (mg/dL) | 112 (97–137) | 101 (91–134) | 105 (98–119) | 0.607 |
|
|
AST, aspartate aminotransferase; ALT, alanine aminotransferase; T-Bil, total bilirubin; Cre, serum creatinine; BUN, blood urea nitrogen; Alb, albumin; BS, blood sugar; DKT, Daikenchuto.
|